Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 01, 2026
Teradyne (TER) Analyst Consensus at $460 Suggests +15% Upside Potential

Teradyne (TER) Analyst Consensus at $460 Suggests +15% Upside Potential

Key Takeaways

  • The central target of $460 is the arithmetic mean of 11 recent, individually attributable analyst price targets, rounded to a clean figure.
  • With Teradyne, Inc. (TER) closing near $400.91, reaching $460 implies a gain of roughly 15%.
  • Analyst targets span a wide range of about $390 to $550, reflecting genuine disagreement on how far the AI-driven upcycle can run.
  • Bullish drivers center on surging AI chip-testing demand, while the main risk is a stretched valuation after a 100%-plus year-to-date rally.
  • The $460 target sits below the stock's June 2026 record high near $488, a notable technical fact for the path ahead.

Analyst Price Targets and Consensus View

Teradyne carries broad analyst coverage, so the $460 central target comes from compiling individual price targets rather than any single firm's outlook. I reviewed 11 recent targets from firms such as Susquehanna ($550), Cantor Fitzgerald ($550), BofA Securities ($525), UBS ($500), Goldman Sachs and J.P. Morgan (each $465), Evercore ISI and Baird (each $420), Citi ($400), Morgan Stanley ($397), and Stifel ($390). That produces a range of roughly $390 to $550 and an arithmetic mean near $462, which rounds cleanly to the $460 figure.

Opinions vary noticeably. The most bullish analysts point to AI-driven demand for semiconductor automated test equipment as justification for premium multiples, supporting targets near $550. More measured views, including Morgan Stanley's Equal-Weight rating and Baird's August downgrade to Neutral citing valuation, suggest much of the upside may already be reflected in the price. The spread underscores that a mean simply averages differing perspectives rather than guaranteeing future performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

Teradyne, Inc. (TER) closed at $400.91 on September 30, 2026, for a market capitalization near $62.7 billion. Reaching $460 would represent a rise of about 15%, a relatively contained move for a stock that has already advanced more than 100% year to date. The shares actually traded above $460 earlier in 2026, peaking near $488 before pulling back over the summer.

The fundamental case rests on Teradyne’s semiconductor-test operations. AI-related applications accounted for more than 60% of fourth-quarter 2025 revenue and were projected to reach up to 70% in early 2026. Management has outlined a longer-term earnings model targeting roughly $6 billion in revenue and non-GAAP EPS of $9.50 to $11, compared with $3.96 in 2025, which could support a meaningfully higher valuation if achieved.

What Could Support a Move Toward the Target

Demand remains the primary driver. AI data-center expansions are widening the system-on-chip and high-bandwidth memory test markets where Teradyne holds a leading position. Fourth-quarter 2025 revenue increased 44% year over year, memory test revenue reached a record, and compute-related test revenue grew roughly 90% for the full year. Analyst revisions have generally trended higher, with several firms raising targets and J.P. Morgan upgrading the stock to Overweight. Additional support comes from the company’s inclusion in the NASDAQ-100 and its diversified portfolio across semiconductor test, robotics, and product test.

What Could Prevent the Target From Being Reached

Valuation presents the clearest hurdle. The stock trades near 55 times trailing earnings and roughly 41 times forward earnings, offering limited cushion for any shortfall. Baird highlighted valuation concerns in its August downgrade. Management has noted that the current surge could be followed by a digestion phase, and visibility into the second half is constrained by the lumpy nature of AI-related orders. Customer concentration in compute and memory testing, competitive pressures, and any slowdown in hyperscaler capital spending could also pressure multiples.

Technical Levels and Market Structure

The 52-week range of $131.75 to $487.91 sets the broader context. The record high near $488, reached in late June 2026, remains the key resistance level above the current price, so the $460 target would require reclaiming territory already visited. Support appears in the $370 to $390 zone from September pullback lows, with the round $400 level serving as a near-term pivot. A decisive break above the prior peak would signal resumption of the broader uptrend.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a 12-month horizon, though assumptions about the duration of the AI cycle differ across firms. The next important catalyst is the quarterly earnings report, expected around October 27, 2026, where guidance on second-half orders and any updates to the revenue and EPS framework will be closely watched. Investors should also follow revisions to analyst targets, trends in memory and SoC test demand, hyperscaler AI capital-expenditure plans, and shifts in valuation multiples.

Final Assessment

Can Teradyne reach $460? The target, a rounded mean of roughly 11 analyst price targets spanning $390 to $550, represents about 15% upside from the recent close near $401. The strongest supports are clear: robust AI chip-test demand, upward analyst revisions, and an ambitious multi-year earnings model. The main obstacles remain a rich valuation, management’s caution about near-term demand lumpiness, and the fact that the stock has already retreated from a higher peak. The path forward likely depends on sustained AI capital spending and execution against guidance, with the next earnings report serving as the key checkpoint.

Using AI Daily Buy/Sell Signals

In my own work tracking momentum in names like Teradyne, I find Tickeron’s AI Daily Buy/Sell Signals helpful for scanning thousands of stocks and ETFs in real time. The tool generates Buy, Sell, or Hold signals based on technical behavior and AI-driven analysis, which can complement traditional research when monitoring positions or spotting trend shifts.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TER

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


TER in upward trend: 10-day moving average crossed above 50-day moving average on September 28, 2026

The 10-day moving average for TER crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on TER as a result. In 59 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for TER just turned positive on September 18, 2026. Looking at past instances where TER's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.

TER moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where TER advanced for three days, in 254 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TER declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

The Aroon Indicator for TER entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. TER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TER's P/B Ratio (18.248) is slightly higher than the industry average of (8.078). P/E Ratio (55.124) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (0.801). Dividend Yield (0.001) settles around the average of (0.002) among similar stocks. P/S Ratio (12.077) is also within normal values, averaging (27.897).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.66B. The market cap for tickers in the group ranges from 326.86K to 671.68B. ASML holds the highest valuation in this group at 671.68B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 8%. For the same Industry, the average monthly price growth was 19%, and the average quarterly price growth was 33%. ACLS experienced the highest price growth at 18%, while TRT experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 4%. For the same stocks of the Industry, the average monthly volume growth was -23% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 34
Price Growth Rating: 44
SMR Rating: 71
Profit Risk Rating: 60
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
TER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an electronic test systems manufacturer

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
600 Riverpark Drive
Phone
+1 978 370-2700
Employees
6600
Web
https://www.teradyne.com
Interact to see
Advertisement
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.
AA shares are surging approximately +11.79% intraday on Monday, March 30, 2026, trading around $64.55 versus Friday's close of approximately $57.74. The primary catalyst is a supply shock in the global aluminum market: two major Middle Eastern aluminum producers — including Bahrain's Aluminium Bahrain (ALBA) — reported being struck by Iranian attacks, raising fears of significant output disruptions.